2022-02-08-世界卫生组织-Consolidated_Financing_Framework_for_ACT-A_Agency_In-Country_Needs_34页_3mb

Consolidated Financing Framework for ACT-A Agency & In-Country Needs

Purpose: To accelerate and facilitate financing for the ACT-Accelerator's 12-month strategic plan (October 2021-September 2022), aligning with its goal of ending the acute COVID-19 pandemic. This framework outlines funding needs for ACT-A agencies and complementary in-country investments, emphasizing equitable access to vaccines, diagnostics, therapeutics, and personal protective equipment (PPE).

Funding Needs Breakdown:

• Total investment required: US$48 billion.
  • US$23.4 billion for ACT-A agencies.
  • US$24.6 billion for complementary in-country delivery costs, including procurement and public health measures.

Financing Sources:

• ACT-A Agencies (US$16.8 billion grant funding):
  • Donor grants from sovereign and private sources required for global public goods, procurement, and delivery support.
  • Key segments: US$0.8 billion for R&D and policy, US$3.0 billion for downstream delivery, US$8.2 billion for procurement, and other categories totaling US$5.8 billion for risk mitigation and country-specific support.
• Complementary Domestic Resources (US$6.5 billion):
  • Domestic financing, supported by multilateral development bank (MDB) funds, to cover procurement in countries like India, Indonesia, and UMICs not facing debt distress.
  • Includes MDB disbursements for vaccine procurement and in-country risks.

Fair Share Model for Voluntary Contributions:

• Based on GDP (using IMF quota approach) and a 4-step formula involving equity adjustments and a 20% risk buffer.
• High-income countries and G20 UMICs are targeted to contribute, with contributions assessed to reach the US$16.8 billion grant funding target.

Tracking and Coordination:

• ACT-A Commitment Tracker monitors real-time contributions, vaccine donations, MDB disbursements, and financial guarantees.
• Sectors tracked include grant funding, in-country delivery support, and country-specific investments.
  -Coordination between donors, countries, and MDBs is emphasized to address gaps.

Conclusion: Urgent action is required for rapid implementation of financing sources to avoid delays that could exacerbate global health inequities and economic losses. ACT-A and in-country needs must be fully funded through a mix of grants, domestic resources, and MDB support.